287 related articles for article (PubMed ID: 25141961)
1. Follicular fluid placental growth factor is increased in polycystic ovarian syndrome: correlation with ovarian stimulation.
Tal R; Seifer DB; Grazi RV; Malter HE
Reprod Biol Endocrinol; 2014 Aug; 12():82. PubMed ID: 25141961
[TBL] [Abstract][Full Text] [Related]
2. Regulation of vascular endothelial growth factor-A and its soluble receptor sFlt-1 by luteinizing hormone in vivo: implication for ovarian follicle angiogenesis.
Gutman G; Barak V; Maslovitz S; Amit A; Lessing JB; Geva E
Fertil Steril; 2008 Apr; 89(4):922-6. PubMed ID: 18343373
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-β1 and its receptor soluble endoglin are altered in polycystic ovary syndrome during controlled ovarian stimulation.
Tal R; Seifer DB; Shohat-Tal A; Grazi RV; Malter HE
Fertil Steril; 2013 Aug; 100(2):538-43. PubMed ID: 23684116
[TBL] [Abstract][Full Text] [Related]
4. Significance of pro-angiogenic estrogen metabolites in normal follicular development and follicular growth arrest in polycystic ovary syndrome.
Henríquez S; Kohen P; Xu X; Villarroel C; Muñoz A; Godoy A; Strauss JF; Devoto L
Hum Reprod; 2020 Jul; 35(7):1655-1665. PubMed ID: 32558920
[TBL] [Abstract][Full Text] [Related]
5. Follicular fluid PlGF/sFlt-1 ratio and soluble receptor for advanced glycation end-products correlate with ovarian sensitivity index in women undergoing A.R.T.
Nejabati HR; Mota A; Farzadi L; Ghojazadeh M; Fattahi A; Hamdi K; Nouri M
J Endocrinol Invest; 2017 Feb; 40(2):207-215. PubMed ID: 27664102
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation.
Artini PG; Monti M; Matteucci C; Valentino V; Cristello F; Genazzani AR
Gynecol Endocrinol; 2006 Aug; 22(8):465-70. PubMed ID: 17012110
[TBL] [Abstract][Full Text] [Related]
7. Alteration in angiogenic potential of granulosa-lutein cells and follicular fluid contributes to luteal defects in polycystic ovary syndrome.
Patil K; Hinduja I; Mukherjee S
Hum Reprod; 2021 Mar; 36(4):1052-1064. PubMed ID: 33377483
[TBL] [Abstract][Full Text] [Related]
8. Follicular fluid levels of anti-Mullerian hormone as a predictor of oocyte maturation, fertilization rate, and embryonic development in patients with polycystic ovary syndrome.
Mashiach R; Amit A; Hasson J; Amzalzg S; Almog B; Ben-Yosef D; Lessing JB; Limor R; Azem F
Fertil Steril; 2010 May; 93(7):2299-302. PubMed ID: 19261276
[TBL] [Abstract][Full Text] [Related]
9. Anti-Müllerian hormone levels to predict oocyte maturity and embryo quality during controlled ovarian hyperstimulation.
Melado Vidales L; Fernández-Nistal A; Martínez Fernández V; Verdú Merino V; Bruna Catalán I; Bajo Arenas JM
Minerva Ginecol; 2017 Jun; 69(3):225-232. PubMed ID: 27352270
[TBL] [Abstract][Full Text] [Related]
10. Comparing serum basal and follicular fluid levels of anti-Müllerian hormone as a predictor of in vitro fertilization outcomes in patients with and without polycystic ovary syndrome.
Arabzadeh S; Hossein G; Rashidi BH; Hosseini MA; Zeraati H
Ann Saudi Med; 2010; 30(6):442-7. PubMed ID: 20940513
[TBL] [Abstract][Full Text] [Related]
11. Serum and follicular fluid irisin levels in women with polycystic ovaries undergoing ovarian stimulation: correlation with insulin resistance and lipoprotein lipid profiles.
Bousmpoula A; Benidis E; Demeridou S; Kapeta-Kourkouli R; Chasiakou A; Chasiakou S; Kouskouni E; Baka S
Gynecol Endocrinol; 2019 Sep; 35(9):803-806. PubMed ID: 30982370
[TBL] [Abstract][Full Text] [Related]
12. Anti-Müllerian hormone dynamics during GNRH-antagonist short protocol for IVF/ICSI in women with varying ovarian reserve levels.
Melado Vidales L; Fernández-Nistal A; Martínez Fernández V; Verdú Merino V; Bruna Catalán I; Bajo Arenas JM
Minerva Ginecol; 2017 Apr; 69(2):128-134. PubMed ID: 27310675
[TBL] [Abstract][Full Text] [Related]
13. Oocyte matched follicular fluid anti-Müllerian hormone is an excellent predictor of live birth after fresh single embryo transfer.
Ciepiela P; Dulęba AJ; Kario A; Chełstowski K; Branecka-Woźniak D; Kurzawa R
Hum Reprod; 2019 Nov; 34(11):2244-2253. PubMed ID: 31725884
[TBL] [Abstract][Full Text] [Related]
14. Adropin levels in women with polycystic ovaries undergoing ovarian stimulation: correlation with lipoprotein lipid profiles.
Bousmpoula A; Kouskouni E; Benidis E; Demeridou S; Kapeta-Kourkouli R; Chasiakou A; Baka S
Gynecol Endocrinol; 2018 Feb; 34(2):153-156. PubMed ID: 28937295
[TBL] [Abstract][Full Text] [Related]
15. Changes and correlations of anti-Müllerian hormone and stem-cell factors in different ovarian reserve patients during GnRH-antagonist protocol and the effects on controlled ovarian hyperstimulation outcomes.
Liu XH; Wu XH; Yang S
Arch Gynecol Obstet; 2019 Dec; 300(6):1773-1783. PubMed ID: 31631249
[TBL] [Abstract][Full Text] [Related]
16. Relations between steroids and AMH: impact of basal and intrafollicular steroids to AMH ratios on oocyte yield and maturation rate in women with or without polycystic ovary undergoing in vitro fertilization.
Hossein G; Arabzadeh S; Hossein-Rashidi B; Hosseini MA
Gynecol Endocrinol; 2012 Jun; 28(6):413-7. PubMed ID: 21992510
[TBL] [Abstract][Full Text] [Related]
17. Predicting the outcome of different protocols of in vitro fertilization with anti-Muüllerian hormone levels in patients with polycystic ovary syndrome.
Chen Y; Ye B; Yang X; Zheng J; Lin J; Zhao J
J Int Med Res; 2017 Jun; 45(3):1138-1147. PubMed ID: 28449632
[TBL] [Abstract][Full Text] [Related]
18. The effect of follicular antimullerian hormone levels of non-obese, non-hyperandrogenemic polycystic ovary syndrome patients on assisted reproduction outcome.
Yilmaz N; Uygur D; Dogan M; Ozgu E; Salman B; Mollamahmutoglu L
Gynecol Endocrinol; 2012 Mar; 28(3):162-5. PubMed ID: 22103791
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor and its soluble receptor in patients with polycystic ovary syndrome undergoing IVF.
Artini PG; Ruggiero M; Parisen Toldin MR; Monteleone P; Monti M; Cela V; Genazzani AR
Hum Fertil (Camb); 2009 Mar; 12(1):40-4. PubMed ID: 19330612
[TBL] [Abstract][Full Text] [Related]
20. Visfatin and leptin levels in women with polycystic ovaries undergoing ovarian stimulation.
Plati E; Kouskouni E; Malamitsi-Puchner A; Boutsikou M; Kaparos G; Baka S
Fertil Steril; 2010 Sep; 94(4):1451-1456. PubMed ID: 19523615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
